Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al
- PMID: 35622446
- PMCID: PMC9347714
- DOI: 10.1111/dth.15602
Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al
Keywords: Covid-19; Pityriasis rosea; hidradenitis suppurativa; lichen planus; psoriasis.
Conflict of interest statement
None of the contributing authors has any conflict of interest, including specific financial interests or relationships and affiliation relevant to the subject matter or discussed materials in the manuscript. All authors equally contributed to the work.
Comment on
-
Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series.Dermatol Ther. 2022 Feb;35(2):e15225. doi: 10.1111/dth.15225. Epub 2021 Dec 1. Dermatol Ther. 2022. PMID: 34816549 Free PMC article. No abstract available.
-
The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.Dermatol Ther. 2022 Aug;35(8):e15601. doi: 10.1111/dth.15601. Epub 2022 Jun 13. Dermatol Ther. 2022. PMID: 35622411 Free PMC article. No abstract available.
References
-
- Villalon‐Gomez JM. Pityriasis Rosea: diagnosis and treatment. Am Fam Physician. 2018;97(1):38‐44. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources